PRGO - Perrigo Company plc
Close
25.505
-0.060 -0.235%
Share volume: 34,780
Last Updated: Fri 27 Dec 2024 08:30:13 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$25.56
-0.06
-0.23%
View ratios
| Fiscal Date | 2022-10-01 | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-31 | 2024-03-30 | 2024-06-29 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-02-27 | 2024-05-07 | 2024-08-02 | |
| Assets | |||||||||
| Total Assets | 10.678 B | 11.017 B | 10.955 B | 10.965 B | 10.758 B | 10.809 B | 10.640 B | 10.397 B | |
| Current Assets | 2.583 B | 2.720 B | 2.741 B | 2.773 B | 2.765 B | 2.833 B | 2.806 B | 2.959 B | |
| Inventories | 1.085 B | 1.150 B | 1.183 B | 1.168 B | 1.150 B | 1.141 B | 1.121 B | 1.116 B | |
| Other Current Assets | 321.700 M | 271.700 M | 266.000 M | 296.200 M | 279.600 M | 201.000 M | 246.600 M | 281.800 M | |
| Short Term Investments | 321.700 M | 271.700 M | 266.000 M | 296.200 M | 279.600 M | 201.000 M | 246.600 M | 281.800 M | |
| Total Receivables | 707.700 M | 697.100 M | 738.700 M | 754.100 M | 737.800 M | 739.600 M | 780.000 M | 726.000 M | |
| Current Cash | 468.700 M | 600.800 M | 553.000 M | 555.200 M | 598.400 M | 751.400 M | 658.500 M | 542.800 M | |
| Total Non-current Assets | 8.094 B | 8.297 B | 8.214 B | 8.192 B | 7.993 B | 7.976 B | 7.834 B | 7.438 B | |
| Property Plant Equipment | 839.900 M | 926.300 M | 919.300 M | 918.300 M | 902.900 M | 916.400 M | 911.400 M | 909.900 M | |
| Other Assets | 541.500 M | 302.600 M | 342.800 M | 307.700 M | 325.200 M | 273.800 M | 288.800 M | 256.300 M | |
| Intangible Assets | 6.495 B | 6.779 B | 6.734 B | 6.689 B | 6.496 B | 6.515 B | 6.368 B | 6.008 B | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.678 B | 11.017 B | 10.955 B | 10.965 B | 10.758 B | 10.809 B | 10.640 B | 10.397 B | |
| Total liabilities | 6.075 B | 6.175 B | 6.121 B | 6.116 B | 6.020 B | 6.041 B | 5.953 B | 5.852 B | |
| Total current liabilities | 1.015 B | 1.114 B | 1.087 B | 1.057 B | 1.008 B | 1.586 B | 1.555 B | 1.488 B | |
| Accounts Payable | 461.400 M | 537.300 M | 505.200 M | 470.500 M | 433.100 M | 477.700 M | 453.700 M | 471.500 M | |
| Other liabilities | 573.200 M | 623.000 M | 637.600 M | 658.700 M | 613.900 M | 559.800 M | 526.200 M | 535.400 M | |
| Current long term debt | 33.500 M | 36.200 M | 38.800 M | 38.400 M | 38.100 M | 440.600 M | 440.600 M | 440.800 M | |
| Long term debt | 4.078 B | 4.070 B | 4.063 B | 4.056 B | 4.049 B | 3.633 B | 3.625 B | 3.617 B | |
| Other liabilities | 573.200 M | 623.000 M | 637.600 M | 658.700 M | 613.900 M | 559.800 M | 526.200 M | 535.400 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.603 B | 4.842 B | 4.834 B | 4.849 B | 4.738 B | 4.768 B | 4.687 B | 4.545 B | |
| Common stock | 134.600 M | 134.800 M | 134.900 M | 135.300 M | 135.500 M | 135.500 M | 136.600 M | 137.100 M | |
| Retained earnings | -2.044 B | -2.068 B | -2.071 B | -2.062 B | -2.048 B | -2.080 B | -2.078 B | -2.187 B |